DXST vs UPC
Comparison between Decent Holding Inc (DXST, Company) and Universe Pharmaceuticals Inc (UPC, Company).
DXST is from the Industrials sector, while UPC is from the Healthcare sector.
DXST vs UPC - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
DXST
$1.65M
Winner
UPC
$1.66M
Max Drawdown
Winner
DXST
98.46%
UPC
99.99%
Sharpe Ratio
DXST
0.35
Winner
UPC
0.35
5Y Beta
DXST
0.73
Winner
UPC
0.51
Industry
DXST
Waste Management
UPC
Drug Manufacturers - Specialty & Generic
P/E Ratio
DXST
0.78
Winner
UPC
-0.00
PEG Ratio
DXST
0.06
UPC
N/A
Debt to Equity
Winner
DXST
0.00%
UPC
3.75%
Free Cash Flow Yield
DXST
-26.75%
UPC
N/A
P/S Ratio
DXST
0.32
UPC
N/A
P/B Ratio
DXST
1.85
UPC
N/A
DXST vs UPC - Historical Returns
Returns include dividend reinvestment.
1M
DXST
+4.52%
Winner
UPC
+8.65%
3M
DXST
-52.44%
Winner
UPC
+26.37%
6M
DXST
-94.26%
Winner
UPC
-33.72%
1Y
DXST
-92.82%
Winner
UPC
-24.87%
5Y(CAGR)
DXST
N/A
UPC
-80.84%
Max(CAGR)
DXST
-94.03%
Winner
UPC
-80.90%
DXST vs UPC - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | DXST | UPC |
|---|---|---|
| 2026 | -94.60% | -31.73% |
| 2025 | -65.76% | -85.20% |
| 2024 | N/A | -97.84% |
| 2023 | N/A | -78.91% |
| 2022 | N/A | -18.54% |
| 2021 | N/A | -65.58% |
DXST vs UPC Drawdown Comparison
The maximum drawdown for DXST was -98.46%, occurring on May 29, 2026. This drawdown has not yet recovered.
The maximum drawdown for UPC was -99.99%, occurring on Mar 25, 2026. This drawdown has not yet recovered.
The current DXST drawdown is -98.18%. The current UPC drawdown is -99.99%.
| Rank | DXST | UPC |
|---|---|---|
| #1 | -98.46% Jan 22, 2025 - May 29, 2026 | -99.99% Apr 5, 2021 - Mar 25, 2026 |
| #2 | N/A | -28.52% Mar 29, 2021 - Apr 5, 2021 |
| #3 | N/A | -14.74% Mar 23, 2021 - Mar 29, 2021 |
Correlation
Correlation between DXST and UPC is 0.41 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.41
-101
Select Stocks to Compare
Popular: DXST vs SPYUPC vs SPY
More Comparisons
Compare with similar stocks